BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1359533)

  • 21. Somatic mutations in stilbene estrogen-induced Syrian hamster kidney tumors identified by DNA fingerprinting.
    Singh KP; Roy D
    J Carcinog; 2004 Mar; 3(1):4. PubMed ID: 15003126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concerted nonsyntenic allelic loss in human colorectal carcinoma.
    Law DJ; Olschwang S; Monpezat JP; Lefrançois D; Jagelman D; Petrelli NJ; Thomas G; Feinberg AP
    Science; 1988 Aug; 241(4868):961-5. PubMed ID: 2841761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community.
    Oliva MR; Ripoll F; Muñiz P; Iradi A; Trullenque R; Valls V; Drehmer E; Sáez GT
    Mol Carcinog; 1997 Apr; 18(4):232-43. PubMed ID: 9142218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clonal analysis of human colorectal tumors.
    Fearon ER; Hamilton SR; Vogelstein B
    Science; 1987 Oct; 238(4824):193-7. PubMed ID: 2889267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fourteen anonymous DNA markers of laboratory rats identified with arbitrarily primed polymerase chain reaction (AP-PCR).
    Kuramoto T; Mashimo T; Serikawa T
    Exp Anim; 1995 Apr; 44(2):119-25. PubMed ID: 7601220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.
    Sidransky D; Tokino T; Hamilton SR; Kinzler KW; Levin B; Frost P; Vogelstein B
    Science; 1992 Apr; 256(5053):102-5. PubMed ID: 1566048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of DNA abnormalities by arbitrarily primed PCR fingerprinting: amplification of the MDM2 gene in a mediastinum fibrosarcoma.
    Kuchiki H; Yasuda J; Kayama T; Murakami Y; Sekiya T
    Biochem Biophys Res Commun; 1999 May; 258(2):271-7. PubMed ID: 10329377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A frequent alteration of p53 gene in carcinoma in adenoma of colon.
    Ohue M; Tomita N; Monden T; Fujita M; Fukunaga M; Takami K; Yana I; Ohnishi T; Enomoto T; Inoue M
    Cancer Res; 1994 Sep; 54(17):4798-804. PubMed ID: 8062281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis.
    Greenwald BD; Harpaz N; Yin J; Huang Y; Tong Y; Brown VL; McDaniel T; Newkirk C; Resau JH; Meltzer SJ
    Cancer Res; 1992 Feb; 52(3):741-5. PubMed ID: 1346256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequent chromosome 8q gains in human small cell lung carcinoma detected by arbitrarily primed-PCR genomic fingerprinting.
    Yamada T; Kohno T; Navarro JM; Ohwada S; Perucho M; Yokota J
    Cancer Genet Cytogenet; 2000 Jul; 120(1):11-7. PubMed ID: 10913671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomic fingerprinting using arbitrarily primed PCR and a matrix of pairwise combinations of primers.
    Welsh J; McClelland M
    Nucleic Acids Res; 1991 Oct; 19(19):5275-9. PubMed ID: 1923811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent deletions involving chromosomes 1, 5, 17, and 18 in colorectal carcinoma: possible role in biological and clinical behavior of tumors.
    Gerdes H; Chen Q; Elahi AH; Sircar A; Goldberg E; Winawer D; Urmacher C; Winawer SJ; Jhanwar SC
    Anticancer Res; 1995; 15(1):13-24. PubMed ID: 7733622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA amplification on chromosome 6p12 in non small cell lung cancer detected by arbitrarily primed polymerase chain reaction.
    De Juan C; Iniesta P; Cruces J; Sanchez A; Massa MJ; Gonzalez-Quevedo R; Torres AJ; Balibrea JL; Benito M
    Int J Cancer; 1999 Aug; 84(4):344-9. PubMed ID: 10404083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
    Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fingerprinting human chromosomes by polymerase chain reaction-mediated DNA amplification.
    Sidhu MS; Helen BK; Athwal RS
    Genomics; 1992 Nov; 14(3):728-32. PubMed ID: 1427900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of Mycobacterium tuberculosis strains by arbitrarily primed polymerase chain reaction-based DNA fingerprinting.
    Lee TY; Lee TJ; Kim SK
    Yonsei Med J; 1994 Sep; 35(3):286-94. PubMed ID: 7975737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous deletion at chromosome 2q33 in human small-cell lung carcinoma identified by arbitrarily primed PCR genomic fingerprinting.
    Kohno T; Morishita K; Takano H; Shapiro DN; Yokota J
    Oncogene; 1994 Jan; 9(1):103-8. PubMed ID: 7905618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotypic analysis of multiple loci in somatic cells by whole genome amplification.
    Barrett MT; Reid BJ; Joslyn G
    Nucleic Acids Res; 1995 Sep; 23(17):3488-92. PubMed ID: 7567460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
    Bergerheim US; Collins VP; Ekman P; Kunimi K
    Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.